The total value of the global sepsis diagnostics market was USD 548.2 million in 2022, and it will rise at a growth rate of above 9.2% shortly, reaching USD 1,109.0 million by 2030. This growth can be attributed to the growing cases of hospital-acquired infections and sepsis and the numerous steps taken by healthcare and also government establishments to aid the research activities associated with its finding.
All admitted patients are susceptible to nosocomial contagion. The main risk reasons for such infections are the utilization of indwelling catheters, extended infirmary stays, overdoing of antibiotics, and fault of the healthcare workers to sanitize their hands. Moreover, HAIs kill more individuals every year worldwide than breast cancer, car accidents, and AIDS. Therefore, there is an extreme requirement to control HAIs.
In 2022, the microbiology category generated the largest revenue share, approximately 50%. Via the utilization of culture media testing, including bacteriology tests, mycobacteriology tests, and serology tests, microbiology permits the measurable identification of microorganisms instigating sepsis.
Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=sepsis-diagnostic-market
The reasons boosting the category development are the growing expenditure in clinical labs, growing knowledge amongst experts and researchers about microbiological testing, and growth in the cases of communicable illnesses.
In 2022, the blood culture media category held the largest market share, at more than 40%. This can be credited to the wide usage of the blood culture technique in sepsis analysis because of its cost-efficiency and easy-to-use nature.
In 2022, the automated diagnostics category dominated the market, owing to its improved traceability, high effectiveness, and removal of repetitive diagnostic practices. Furthermore, the surge in the need for the timely treatment of the disorder and the execution of numerous plans by key players, like spreading their product portfolio, mergers and attainments, and partnerships are driving the category development.
In 2022, the bacterial sepsis category held the largest industry share of around 80%, and the category is also projected to advance at the highest CAGR, more than 8%, in the coming few years. This is mainly because of the surge in bacterial sepsis occurrence, spur in the frequency of HAIs and surge in the count of surgical procedures. According to a government association, among all the pathogens, bacteria are the most common reason for septicemia.
In 2022, North America led the sepsis diagnostics market with approximately 40% share. This can be credited to the high mortality rates related to sepsis in the continent. Recently, an American government association specified that in an average year, 2 million Americans grow sepsis and 1 in 3 patients expire in hospitals following onset.
Hence, the growing cases of hospital-acquired infections and sepsis and the numerous steps taken by healthcare and also government establishments to aid the research activities associated with its finding are the major factors propelling the industry.